MCM蛋白在消化系统肿瘤的研究进展

doi:10.11904/j.issn.1002-3070.2021.05.008

实用肿瘤学杂志 ›› 2021, Vol. 35 ›› Issue (5): 431-435.doi: 10.11904/j.issn.1002-3070.2021.05.008

MCM蛋白在消化系统肿瘤的研究进展

商昌权¹, 李国东¹, 魏九峰¹ 综述, 刘明² 校审

1.哈尔滨医科大学附属第四医院普外科(哈尔滨 150001);
2.哈尔滨医科大学附属第二医院普外科

收稿日期:2020-11-17 修回日期:2021-03-03 出版日期:2021-10-28 发布日期:2021-10-25
通讯作者: 刘明,E-mail:Mliu35@aliyun.com
作者简介:商昌权,男,(1993-),硕士研究生,从事胃肠道肿瘤的研究。
基金资助:
国家自然科学基金面上项目(编号:82072673)

Research progress of MCM protein in digestive system tumors

SHANG Changquan¹, LI Guodong¹, WEI Jiufeng¹, LIU Ming²

1. Department of General Surgery,The Fourth Affiliated Hospital of Harbin Medical University,Harbin 150001,China;
2. Department of General Surgery,The Second Affiliated Hospital of Harbin Medical University

Received:2020-11-17 Revised:2021-03-03 Online:2021-10-28 Published:2021-10-25

摘要/Abstract

摘要： 微小染色体维持(Minichromosome maintenance,MCM)蛋白是真核细胞DNA复制过程中的重要物质,参与了DNA复制的始动及延长。由于某些因素导致MCM蛋白表达异常时,静止期的细胞开始新的细胞周期,DNA发生异常复制,细胞开始无限增殖,致使肿瘤的产生,因此MCM蛋白被认为是一种新的肿瘤标志物。消化系统肿瘤与MCM蛋白关系密切,探索MCM蛋白可以为消化系统肿瘤的诊断和治疗带来新的方法。

关键词: 微小染色体维持蛋白, 消化系统肿瘤, 肿瘤标志物

Abstract: Minichromosome maintenance(MCM)proteins are important substances in the DNA replication process of eukaryotic cells,and are involved in the initiation and elongation of DNA replication.When certain factors cause the abnormal expression of MCM protein,cells in the quiescent phase start a new cell cycle,abnormal DNA replication occurs,and cells begin to proliferate indefinitely,resulting in tumorigenesis.Therefore,MCM protein is considered as a new tumor marker.Digestive system tumors are closely related to MCM protein.Exploring the MCM protein can bring new methods for the diagnosis and treatment of digestive system tumors.

Key words: Minichromosome maintenance protein, Digestive system tumor, Tumor marker

中图分类号:

R735

商昌权, 李国东, 魏九峰, 刘明. MCM蛋白在消化系统肿瘤的研究进展[J]. 实用肿瘤学杂志, 2021, 35(5): 431-435.

SHANG Changquan¹, LI Guodong¹, WEI Jiufeng¹, LIU Ming². Research progress of MCM protein in digestive system tumors[J]. Journal of Practical Oncology, 2021, 35(5): 431-435.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/10.11904/j.issn.1002-3070.2021.05.008

http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/Y2021/V35/I5/431

参考文献

1 Kelly TJ,Brown GW.Regulation of chromosome replication[J].Annu Rev Biochem,2000,69:829-880.
2 Yu S,Wang G,Shi Y,et al.MCMs in cancer:prognostic potential and mechanisms[J].Anal Cell Pathol,2020,2020:3750294.
3 Wang Y,Chen H,Zhang J,et al.MCM family in gastrointestinal cancer and other malignancies:From functional characterization to clinical implication[J].Biochim Bio Phys Acta Rev Cancer,2020,1874(2):188415.
4 Bochman ML,Schwacha A.The Mcm2-7 complex has in vitro helicase activity[J].Molecular Cell,2008,31(2):287-293.
5 Nowińska K,Dzigiel P.The role of MCM proteins in cell proliferation and tumorigenesis[J].Postepy Hig Med Dosw(Online),2010,64:627-635.
6 You Z,Ishimi Y,Masai H,et al.Roles of Mcm7 and Mcm4 subunits in the DNA helicase activity of the mouse Mcm4/6/7 complex[J].J Biol Chem,2002,277(45):42471-42479.
7 Cannone G,Visentin S,Palud A,et al.Structure of an octameric form of the minichromosome maintenance protein from the archaeon pyrococcus abyssi[J].Sci Rep,2017,8(7):42019.
8 Masai H,Matsumoto S,You ZY,et al.Eukaryotic chromosome DNA replication:where,when,and how?[J].Annu Rev Biochem,2010,79:89-130.
9 Truong LN,Wu XH.Prevention of DNA re-replication in eukaryotic cells[J].J Mol Cell Biol,2011,3(1):13-22.
10 Kanemaki MT.The dimeric Mcm8-9 complex of Xenopus laevis likely has a conserved function for resistance to DNA damage[J].Cell Cycle,2013,12(9):1338-1339.
11 Bastajian N,Friesen H,Andrews BJ.Bck2 acts through the MADS box protein Mcm1 to activate cell-cycle-regulated genes in budding yeast[J].PLoS Genet,2013,9(5):e1003507.
12 Thu YM,Bielinsky AK.MCM10:one tool for all-Integrity,maintenance and damage control[J].Semin Cell Dev Biol,2014,6(30):121-30.
13 黄晓平,张旭,苏晓东,等.MCM4在食管癌组织中的表达与临床病理的关系[J].癌症,2007,23:(1):96-99.
14 Choy B,LaLonde A,Que J,et al.MCM4 and MCM7,potential novel proliferation markers,significantly correlated with Ki-67,Bmi1,and cyclin E expression in esophageal adenocarcinoma,squamous cell carcinoma,and precancerous lesions[J].Hum Pathol,2016,57:126-135.
15 Sirieix PS,O'Donovan M,Brown J,et al.Surface expression of minichromosome maintenance proteins provides a novel method for detecting patients at risk for developing adenocarcinoma in Barrett's esophagus[J].Clin Cancer Res,2003,9(7):2560-2566.
16 Huang B,Hu B,Su M,et al.Potential role of minichromosome maintenance protein 2 as a screening biomarker in esophageal cancer high-risk population in China[J].Hum Pathol,2011,42(6):808-816.
17 Liu M,Li JS,Tian DP,et al.MCM2 expression levels predict diagnosis and prognosis in gastric cardiac cancer[J].Histol Histopathol,2013,28(4):81-92.
18 荣芳,王勇,王满贵,等.微小染色体维持蛋白4在胃癌中的表达及与幽门螺杆菌感染的关系[J].癌变·畸变·突变,2010,22(4):279-282.
19 Giaginis C,Giagini A,Tsourouflis G,et al.MCM-2 and MCM-5 expression in gastric adenocarcinoma:clinical significance and comparison with Ki-67 proliferative marker[J].Dig Dis Sci,2011,56(3):777-785.
20 谭宁平,李莉,张文静,等.MCM8在胃癌中的表达及其与临床病理特征及预后的相关性分析[J].胃肠病学和肝病学杂志,2020,29(10):1109-1113.
21 Guo F,Kong WN,Feng YC,et al.Comprehensive analysis of the expression and prognosis for MCMs in human gastric cancer[J].Technol Cancer Res Treat,2020,10(19):1-13.
22 Wei K,Joanna T,Anthony C,et al.MCM7 serves as a prognostic marker in diffuse-type gastric adenocarcino mand siRNA-mediated knockdown suppresses its oncogenic function[J].Oncol Rep,2014,31(5):2071-2078.
23 Liu Z,Li J,Chen J,et al.MCM family in HCC:MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression[J].Bio Med Central,2018,18(1):200.
24 Yan L,Liang X,Huang H,et al.Adenosylmethionine affects cell cycle pathways and suppresses proliferation in liver cells[J].J Cancer,2019,10(18):4368-4379.
25 Nan YL,Hu YL,Liu ZK,et al.Relationships between cell cycle pathway gene polymorphisms and risk of hepatocellular carcinoma[J].World J Gastroenterol,2016,22(24):5558-5567.
26 Liao X,Liu X,Yang C,et al.Distinct diagnostic and prognostic values of minichromosome maintenance gene expression in patients with hepatocellular carcinoma[J].J Cancer,2018,9(13):2357-2373.
27 Ishibashi Y,Kinugasa T,Akagi Y,et al.Minichromosome maintenance protein 7 is a risk factor for recurrence in patients with Dukes C colorectal cancer[J].Anticancer Res,2014,34(8):4569-4575.
28 Nishihara K,Shomori K,Fujioka S,et al.Minichromosome maintenance protein 7 in colorectal cancer:implication of prognostic significance[J].Int J Oncol,2008,33(2):245-251.
29 Giaginis C,Georgiadou M,Dimakopoulou K,et al.Clinical significance of MCM-2 and MCM-5 expression in colon cancer:association with clinicopathological parameters and tumor proliferative capacity[J].Dig Dis Sci,2009,54(2):282-291.
30 Scarpini C,White V,Muralidhar B,et al.Improved screening for anal neoplasia by immunocytochemical detection of minichromosome maintenance proteins[J].Cancer Epidemiol Biomarkers Prev,2008,17(10):2855-2864.
31 Abe N,Matsuo K,Kumasaka T,et al.Systematic cytological evaluation and immunocytochemistry of minichromosome maintenance protein 2 and p53 significantly improve cytological diagnosis of pancreaticobiliary adenocarcinoma[J].J Med Dent Sci,2016,63(1):19-27.
32 Keane MG,Huggett MT,Chapman MH,et al.Diagnosis of pancreaticobiliary malignancy by detection of minichromosome maintenance protein 5 in biliary brush cytology[J].Br J Cancer,2017,116(3):349-355.
33 Liao X,Han C,Wang X,et al.Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy[J].Cancer Manag Res,2018,10:3255-3271.
34 Peng YP,Zhu Y,Yin LD,et al.The expression and prognostic roles of MCMs in pancreatic cancer[J].PLoS One,2016,11(10):e0164150.
35 Lei M.The MCM complex:its role in DNA replication and implications for cancer therapy[J].Curr Cancer Drug Targets,2005,5(5):365-380.
36 王蕾,余波光,吴文言.MBP-hmcm6融合蛋白的构建与表达[J].实用肿瘤学杂志,2005,19(5):321-324.

[1]	马明瑞, 连洁, 刘超, 娄长杰, 张艳桥. 消化系统肿瘤“免疫治疗前移”的探索[J]. 实用肿瘤学杂志, 2021, 35(3): 258-262.
[2]	张佳文,于雁,张薇,曹京燕,罗雯,尚利华. 基于UPLC-TOF/MS的小细胞肺癌患者血清代谢组学研究[J]. 实用肿瘤学杂志, 2019, 33(3): 200-205.
[3]	韩帮岭, 汪亦民综述, 薛英威审校. 维生素D在消化系统肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2018, 32(5): 471-475.
[4]	万静萱, 李红红, 周湘乡, 马琳. Ⅳ期肺癌合并肺血栓栓塞的危险因素分析[J]. 实用肿瘤学杂志, 2018, 32(3): 214-244.
[5]	唐志坚,崔恒. 人附睾蛋白4(HE4)在卵巢癌的诊断及预后研究的新进展[J]. 实用肿瘤学杂志, 2013, 27(3): 193-197.
[6]	张明岩, 蔡莉. 血清相关肿瘤标志物联合检测在乳腺癌复发转移中的作用[J]. 实用肿瘤学杂志, 2011, 25(5): 493-496.
[7]	张鹏宇, 李媛媛, 李明琦, 石学魁, 陶冀, 肖琳, 王亚贤. 血清促血管生成素在肝癌中的表达及影响[J]. 实用肿瘤学杂志, 2010, 24(6): 512-514.
[8]	杨桐树, 李文辉, 孙喜文. 血清五种肿瘤标志物联合检测在肺癌诊断中的意义[J]. 实用肿瘤学杂志, 2010, 24(3): 243-246.
[9]	赵健, 徐维, 王远东, 郭爱林, 薛兴阳, 李洪胜, 韩国栋, 傅文凡. 应用蛋白芯片技术筛选肺腺癌化疗敏感血清蛋白标志物[J]. 实用肿瘤学杂志, 2010, 24(1): 20-23.
[10]	亢澜涛. 肿瘤标志物的跟踪检测在肺癌化疗中的应用价值[J]. 实用肿瘤学杂志, 2009, 23(1): 54-55.
[11]	林哲洙;侯柯佐;金锋. C-12型蛋白芯片在乳腺癌诊断中的临床价值[J]. 实用肿瘤学杂志, 2008, 22(04): 309-312.
[12]	任瑞霞;宫存杞. 血清补体C3a检测在结肠癌诊断中的价值[J]. 实用肿瘤学杂志, 2008, 22(02): 144-145.
[13]	任瑞霞;宫存杞. 血清补体Ca3+检测在结肠癌诊断中的价值[J]. 实用肿瘤学杂志, 2008, 22(01): 43-44.
[14]	杜同信;王自正;傅雷;俞杨;张保国;田韧;周宝宁. 多肿瘤标志物蛋白芯片检测系统在恶性肿瘤诊断中的应用[J]. 实用肿瘤学杂志, 2007, 21(01): 32-34,1.
[15]	凤敏华. 多项肿瘤标志物对肺癌诊断的临床意义[J]. 实用肿瘤学杂志, 2007, 21(01): 44-46.

MCM蛋白在消化系统肿瘤的研究进展

Research progress of MCM protein in digestive system tumors

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价